Gossamer Bio, Inc. ( NASDAQ:GOSS) shareholders will have a reason to smile today, with the analysts making substantial upgrades to next year's statutory forecasts. The consensus estimated revenue ...
Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary ...
"Now the work begins to dismantle the pro-abortion policies of the Biden-Harris administration," the Susan B. Anthony List, the powerful anti-abortion lobby, said in a statement Wednesday. "President ...